Global Viral Clearance Service Market Growth (Status and Outlook) 2025-2031
The global Viral Clearance Service market size is predicted to grow from US$ 559 million in 2025 to US$ 1603 million in 2031; it is expected to grow at a CAGR of 19.2% from 2025 to 2031.
Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.
North America is the largest Viral Clearance Service market with about 51% market share. Europe is follower, accounting for about 23% market share.The key manufacturers are Charles River, BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Mérieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merk etc. Top 3 companies occupied about 39% market share.
LPI (LP Information)' newest research report, the “Viral Clearance Service Industry Forecast” looks at past sales and reviews total world Viral Clearance Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Viral Clearance Service sales for 2025 through 2031. With Viral Clearance Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Clearance Service industry.
This Insight Report provides a comprehensive analysis of the global Viral Clearance Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Clearance Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Clearance Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Clearance Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Clearance Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Clearance Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Basic Service
Enhanced Service
Full Service
Turnkey Service
Segmentation by Application:
Research Institution
Pharmaceutical Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Sigma-Aldrich (Merck)
Eurofins Scientific
Sartorius
Labcorp
ViruSure
Texcell
Bioscience Labs
Vironova Biosafety
Mérieux NutriSciences
WuXi AppTec
Syngene
Labor Dr. Merk (Boehringer Ingelheim)
Sino Biological
Please note: The report will take approximately 2 business days to prepare and deliver.